
Company Info
Phone(917) 289-1117
Year Established
2014
Ticker
EYEN
Exchange
NASDAQ
Contacts
Michael RoweCEO
John Gandolfo
CFO
Sean Ianchulev
Chair
Bren Kern
COO
Norbert Lowe
VP, Commercial
Company Description
Eyenovia is a late-stage ophthalmic biopharmaceutical company developing breakthrough treatments for front and back-of-the-eye diseases, which are made possible by the company's transformative, high precision ophthalmic delivery platform.